Analyst Downgrades – NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO) Stock Gets Downgraded By BMO Capital Markets from Outperform ➝ Market Perform to

Analyst Ratings For NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO)

Story continues below

Today, NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO) stock was downgraded by BMO Capital Markets from Outperform ➝ Market Perform to .

Some recent analyst ratings include

  • 5/10/2018-BMO Capital Markets was Downgraded by analysts at BMO Capital Markets from a “Outperform ➝ Market Perform” rating to a “” rating.
  • 5/10/2018-Leerink Swann was Downgraded by analysts at Leerink Swann from a “Outperform ➝ Market Perform” rating to a “” rating. They now have a $50.00 price target on the stock.
  • 2/20/2018-Robert W. Baird initiated coverage with a Outperform rating.
  • 2/20/2018-Jefferies Group initiated coverage with a Buy ➝ Buy rating.


    Recent Trading Activity for NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO)
    Shares of NASDAQ:ARMO – ARMO BioSciences closed the previous trading session at 49.80 up +19.98 67.00% with 49.7599983215332 shares trading hands.

    An ad to help with our costs